CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Exercise or conversion | +36,375 | 36,375 | ||
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Shares withheld for taxes | −9,330 | $4.41 | $41K | 27,045 |
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −36,375 | 109,125 | ||
| 2026-02-02 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Restricted Stock Units | +98,100 | 98,100 | ||
| 2026-02-02 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +343,300 | 343,300 | ||
| 2025-05-01 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Restricted Stock Units | +145,500 | 145,500 | ||
| 2025-05-01 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +510,000 | 510,000 |
Page 1 of 1 · 7 trades